1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Factor IX -Pipeline Insights, 2017

Factor IX -Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “Factor IX-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Factor IX. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Factor IX. DelveInsight’s Report also assesses the Factor IX therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitive pipeline landscape of Factor IX
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Factor IX pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Factor IX and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Factor IX -Pipeline Insights, 2017
Illustrative

- Factor IX Overview
- Factor IX Disease Associated
- Factor IX Pipeline Therapeutics
- Factor IX Therapeutics under Development by Companies
- Factor IX Filed and Phase III Products
- Comparative Analysis
- Factor IX Phase II Products
- Comparative Analysis
- Factor IX Phase I and IND Filed Products
- Comparative Analysis
- Factor IX Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Factor IX - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Factor IX - Discontinued Products
- Factor IX - Dormant Products
- Companies Involved in Therapeutics Development for Factor IX
- Appendix
- Methodology
- Contact Us
- Disclaimer



List of Tables

- Number of Products under Development for Factor IX by Therapy Area, 2017
- Number of Products under Development for Factor IX, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Factor IX Assessment by Monotherapy Products
- Factor IX Assessment by Combination Products
- Factor IX Assessment by Route of Administration
- Factor IX Assessment by Stage and Route of Administration
- Factor IX Assessment by Molecule Type
- Factor IX Assessment by Stage and Molecule Type
- Factor IX Therapeutics - Discontinued Products
- Factor IX Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Factor IX by Therapy Area, 2017
- Number of Products under Development for Factor IX, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Factor IX Assessment by Monotherapy Products
- Factor IX Assessment by Combination Products
- Factor IX Assessment by Route of Administration
- Factor IX Assessment by Stage and Route of Administration
- Factor IX Assessment by Molecule Type
- Factor IX Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Factor IX Deficiency Treatment Market 2017-2021

Global Factor IX Deficiency Treatment Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Factor IX Deficiency Treatment The global factor IX deficiency treatment market is characterized by the presence of various therapeutic products provided by some of the top vendors such as Shire, ...

Factor IX A Inhibitors -Pipeline Insights, 2017

Factor IX A Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Factor IX A Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Factor IX A Inhibitors. The ...

Global Markets for Protein Labeling

Global Markets for Protein Labeling

  • $ 6650
  • Industry report
  • February 2017
  • by BCC Research

Use this report to: - Identify key market dynamics and the factors impacting the global protein-labeling market and its subsegments. - Gain insight into global protein-labeling market and its market segments, ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.